Detalhe da pesquisa
1.
The biological underpinnings of therapeutic resistance in pancreatic cancer.
Genes Dev
; 35(13-14): 940-962, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34117095
2.
ATDC binds to KEAP1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancer.
Genes Dev
; 35(3-4): 218-233, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33446568
3.
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma.
CA Cancer J Clin
; 70(5): 375-403, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32683683
4.
ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis.
Genes Dev
; 33(11-12): 641-655, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31048544
5.
Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence Meta-analysis to Estimate the Rate of Low-yield Surgery.
Ann Surg
; 279(1): 37-44, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37681303
6.
The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals.
J Natl Compr Canc Netw
; 22(3): 158-166, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626807
7.
Progression of Site-Specific Recurrence of Pancreatic Cancer and Implications for Treatment.
Ann Surg
; 2023 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870253
8.
Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment.
Gastroenterology
; 163(2): 386-402.e1, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35398344
9.
ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis.
Genes Dev
; 29(2): 171-83, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25593307
10.
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer.
Gastroenterology
; 160(1): 362-377.e13, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33039466
11.
Standardization of EUS imaging and reporting in high-risk individuals of pancreatic adenocarcinoma: consensus statement of the Pancreatic Cancer Early Detection Consortium.
Gastrointest Endosc
; 95(4): 723-732.e7, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34736932
12.
Standardization of MRI Screening and Reporting in Individuals With Elevated Risk of Pancreatic Ductal Adenocarcinoma: Consensus Statement of the PRECEDE Consortium.
AJR Am J Roentgenol
; 219(6): 903-914, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35856454
13.
Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer.
Gut
; 70(4): 743-760, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32873698
14.
Cancer surveillance awareness and practice among families at increased risk for pancreatic adenocarcinoma.
Cancer
; 127(13): 2271-2278, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33721345
15.
A novel target for combination immunotherapy in pancreatic cancer: IL-1ß mediates immunosuppression in the tumour microenvironment.
Br J Cancer
; 124(11): 1754-1756, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758330
16.
HIF1-alpha Regulates Acinar Cell Function and Response to Injury in Mouse Pancreas.
Gastroenterology
; 154(6): 1630-1634.e3, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29409830
17.
Multiplex Enrichment and Detection of Rare KRAS Mutations in Liquid Biopsy Samples using Digital Droplet Pre-Amplification.
Anal Chem
; 91(12): 7516-7523, 2019 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31072097
18.
Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing.
Am J Gastroenterol
; 114(9): 1539-1549, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31306149
19.
Scalable Multiplexed Drug-Combination Screening Platforms Using 3D Microtumor Model for Precision Medicine.
Small
; 14(42): e1703617, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30239130
20.
Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer.
Gut
; 66(1): 124-136, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27402485